Updated Jul 16, 2026
Tamayo Louis Edward has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $21K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | LXEO | Lexeo Therapeutics, Inc. | S — Open-market sale | 4.6K | $4.49 | $21K |
| 2026-07-01 | LXEO | Lexeo Therapeutics, Inc. | A — Grant or award | 12.0K | $0.00 | |
| 2026-02-06 | LXEO | Lexeo Therapeutics, Inc. | A — Grant or award | 44.7K | $0.00 | |
| 2025-08-29 | LXEO | Lexeo Therapeutics, Inc. | A — Grant or award | 45.0K | $0.00 |
Tamayo Louis Edward is a corporate insider — currently tracked as Insider of Lexeo Therapeutics, Inc. (LXEO). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($21K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tamayo Louis Edward profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.